Background: Evidence on the effectiveness of proton pump inhibitors (PPI) as adjuvant therapy to im-prove maldigestion in people with cystic fibrosis (pwCF) is limited and there is increasing concern on possible side effects.Methods: We conducted a matched cohort study based on paediatric and adult pwCF who received PPI for >= 3 months. Treated patients were matched to a group of patients who never received PPI using a nearest neighbour propensity score matching based on sex, year of birth, CFTR genotype and pancreatic insufficiency. Results: The study included 160 pwCF: 80 treated and 80 untreated patients. Over a median follow-up of 2 years, no significant differences in changes in BMI z-score were detected between groups (adjusted mean difference: 0.06, 95% CI:-0.17-0.30). At baseline 25% ( n = 20) of the treated patients and 22.5% ( n = 18) of the untreated patients had a positive culture for P. aeruginosa (Pa). At follow-up percentages of Pa positive cultures increased to 47.5% ( n = 38) in the treated group and to 26.3% ( n = 21) in the untreated group (adjusted mean difference: 23.1%, 95% CI: 10.8-35.3). Conclusions: Prolonged PPI therapy should be used cautiously in pwCF since it may increase the risk of respiratory infection by Pa. In addition, such treatment does not seem to improve nutritional status .(c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Effects of prolonged proton pump inhibitor treatment on nutritional status and respiratory infection risk in cystic fibrosis: A matched cohort study / L. Zazzeron, G. Alicandro, V. Daccò, C. Lanfranchi, A. Bulfamante, C. Sathya Sciarrabba, F. Corti, C. Colombo. - In: DIGESTIVE AND LIVER DISEASE. - ISSN 1878-3562. - 55:3(2023), pp. 360-365. [10.1016/j.dld.2022.09.005]

Effects of prolonged proton pump inhibitor treatment on nutritional status and respiratory infection risk in cystic fibrosis: A matched cohort study

G. Alicandro
Secondo
;
C. Lanfranchi;
2023

Abstract

Background: Evidence on the effectiveness of proton pump inhibitors (PPI) as adjuvant therapy to im-prove maldigestion in people with cystic fibrosis (pwCF) is limited and there is increasing concern on possible side effects.Methods: We conducted a matched cohort study based on paediatric and adult pwCF who received PPI for >= 3 months. Treated patients were matched to a group of patients who never received PPI using a nearest neighbour propensity score matching based on sex, year of birth, CFTR genotype and pancreatic insufficiency. Results: The study included 160 pwCF: 80 treated and 80 untreated patients. Over a median follow-up of 2 years, no significant differences in changes in BMI z-score were detected between groups (adjusted mean difference: 0.06, 95% CI:-0.17-0.30). At baseline 25% ( n = 20) of the treated patients and 22.5% ( n = 18) of the untreated patients had a positive culture for P. aeruginosa (Pa). At follow-up percentages of Pa positive cultures increased to 47.5% ( n = 38) in the treated group and to 26.3% ( n = 21) in the untreated group (adjusted mean difference: 23.1%, 95% CI: 10.8-35.3). Conclusions: Prolonged PPI therapy should be used cautiously in pwCF since it may increase the risk of respiratory infection by Pa. In addition, such treatment does not seem to improve nutritional status .(c) 2022 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.
Cystic fibrosis; Nutritional status; Proton pump inhibitors; Respiratory infections
Settore MED/12 - Gastroenterologia
2023
Article (author)
File in questo prodotto:
File Dimensione Formato  
Effects of prolonged proton pump inhibitor treatment on nutritional status and respiratory infection risk in CF.pdf

accesso riservato

Descrizione: Article
Tipologia: Publisher's version/PDF
Dimensione 468.5 kB
Formato Adobe PDF
468.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/976608
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 3
social impact